Clinical Trial Update: Stereotactic Body Radiation Therapy in Treating Patients With Metastatic or Recurrent Kidney Cancer [NA]

View source ↗

Summary

A trial evaluating stereotactic body radiation therapy for metastatic or recurrent renal cell carcinoma was terminated; results were posted in May 2024.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Snippet

Sponsor: University of Chicago | Conditions: Metastatic Renal Cell Cancer, Recurrent Renal Cell Carcinoma | NA | Status: TERMINATED | Results posted: 2024-05-30